Am. Duncan et al., Premenopausal equol excretors show plasma hormone profiles associated withlowered risk of breast cancer, CANC EPID B, 9(6), 2000, pp. 581-586
Increased urinary excretion of equol, a metabolite of the isoflavone daidze
in. has been associated with a reduced risk of breast cancer. This risk red
uction has generally been presumed to be a consequence of increased isoflav
one consumption. However, only 30-40% of the population excretes more than
trace amounts of equol, regardless of isoflavone intake. Accordingly, we hy
pothesized that the observed apparent protective effect of equol is at leas
t in part attributable to hormonal differences between equol excretors and
non-excretors, and that these differences are largely independent of isofla
vone intake.
We measured plasma hormone and sex hormone binding globulin (SHBG) concentr
ations in 14 normally cycling premenopausal women during each of three diet
periods in which they consumed differing isoflavone doses (0.15, 1.0, and
2.0 mg/kg of body weight/day) as a component of soy protein isolate. The pl
asma hormone and SHBG concentrations of equol excreters (n = 5) were then c
ompared with those of the non-excretors (n = 9), Results showed that even a
t the lowest dose, urinary equol excretion values for excreters far exceede
d those for non-excretors consuming the highest dose. At all doses, equol e
xcreters generally had lower concentrations of estrone, estrone-sulfate, te
stosterone, androstenedione, dehydroepiandrosterone (DHEA), DHEA-sulfate, a
nd cortisol and higher concentrations of SHBG and midluteal progesterone, a
hormonal pattern overall consistent with lowered breast cancer risk. In co
nclusion, the association of equol excretion and lowered breast cancer risk
may largely reflect the tendency of equol excreters to have more favorable
hormonal profiles, as opposed to merely reflecting increased isoflavone in
take. Equol may be a marker for the presence of colonic bacterial enzymatic
activity that increases fecal steroid excretion. Alternatively, equol itse
lf, even with very modest isoflavone intake, may exert beneficial effects o
n the regulation of endogenous hormones.